Heterogeneous Causes of Acute Respiratory Distress Syndrome Correlate With Distinct Peripheral Polyunsaturated Fatty Acid Metabolites
The FASEB Journal · 31.05.2026 · 40 (10)
DOI: 10.1096/fj.202504787rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 13.05.2026. Verfasst von Laura A Leuenberger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and The Davis Heart and Lung Research Institute, The Ohio St…. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Fatty Acids, Unsaturated, Fatty Acids, Omega-3. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS|NIH|National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS, CHEST Foundation (CHEST Philanthropy).
Abstract (Originalsprache)
Acute Respiratory Distress Syndrome (ARDS), a heterogeneous syndrome of hypoxic respiratory failure secondary to dysregulated pulmonary inflammation, is caused by diverse insults. This heterogeneity presents challenges for mechanistic and therapeutic research, as evidenced by conflicting results from trials of n−3 polyunsaturated fatty acid (PUFA) supplementation for ARDS. PUFAs and downstream oxylipins are important to pulmonary inflammation but are not well defined in ARDS. We hypothesized that differences in fatty acid metabolism, as measured by levels of n−3 and n−6 PUFAs and oxylipins, are associated with differences in ARDS outcomes, inflammation, and causes. To test this, PUFAs/oxylipins were measured by LC MS/MS in plasma samples from 90 patients with ARDS. Pro‐inflammatory cytokines and chemokines IL‐6 and IL‐8 were measured by ELISA. Multivariable linear regressions modeled the relationship between PUFAs/oxylipins, inflammation, and ARDS mortality, severity, and cause. Multiple n−3 and n−6 PUFA‐derived oxylipins were decreased in severe ARDS. We did not detect differences in PUFAs/oxylipins by mortality. PUFAs/oxylipins varied by cause of ARDS, especially between patients with sepsis and those with trauma. Furthermore, specific oxylipins were associated with IL‐6 and IL‐8. As we observed that oxylipins varied by disease severity and underlying cause, these metabolites may function as biomarkers and suggest dysregulated mechanisms of lung repair. Furthermore, while oxylipins are derived from PUFAs, differences in PUFAs did not directly correlate with changes in oxylipins, suggesting altered lipid metabolism as a mechanism. Further consideration of differences in lipid metabolism in ARDS could identify subgroups with differential responses to n−3 PUFA supplementation or other therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.
- Benaroya Institute, Seattle, Washington, USA.
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Center for Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Medicine, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Laura A Leuenberger, Joseph S Bednash, Evangeline Schott, Carmen Mikacenic, Eric D Morrell, Carson Richardson, Lynn A Fussner, Jeffrey C Horowitz, Rama K Mallampalli, Saame Raza Shaikh, Robert M Tighe, Kymberly M Gowdy
Förderung
- HHS|NIH|National Heart, Lung, and Blood Institute (NHLBI)
- NHLBI NIH HHS
- CHEST Foundation (CHEST Philanthropy)
- HHS|National Institutes of Health (NIH)
- HHS|NIH|National Center for Advancing Translational Sciences (NCATS)
- National Center for Advancing Translational Sciences
- National Heart, Lung, and Blood Institute
- National Institutes of Health
Zitieren
APA
Leuenberger, L. A., Bednash, J. S., Schott, E., Mikacenic, C., Morrell, E. D., Richardson, C., Fussner, L. A., Horowitz, J. C., Mallampalli, R. K., Shaikh, S. R., Tighe, R. M., & Gowdy, K. M. (2026). Heterogeneous Causes of Acute Respiratory Distress Syndrome Correlate With Distinct Peripheral Polyunsaturated Fatty Acid Metabolites. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202504787rr
Vancouver
Leuenberger LA, Bednash JS, Schott E, Mikacenic C, Morrell ED, Richardson C, et al. Heterogeneous Causes of Acute Respiratory Distress Syndrome Correlate With Distinct Peripheral Polyunsaturated Fatty Acid Metabolites. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202504787rr
BibTeX
@article{Leuenberger2026,
author = {Leuenberger, Laura A and Bednash, Joseph S and Schott, Evangeline and Mikacenic, Carmen and Morrell, Eric D and Richardson, Carson and Fussner, Lynn A and Horowitz, Jeffrey C and Mallampalli, Rama K and Shaikh, Saame Raza and Tighe, Robert M and Gowdy, Kymberly M},
title = {Heterogeneous Causes of Acute Respiratory Distress Syndrome Correlate With Distinct Peripheral Polyunsaturated Fatty Acid Metabolites},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {10},
doi = {10.1096/fj.202504787rr}
}
EUVIMED